Approvals/TGA/PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 10mL injection vial

Approved

STANDARD

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 10mL injection vial

Bayer Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4f6d43d4de985bed
Product Name: PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 10mL injection vial
Artg Id: 104379
Artg Name: PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 10mL injection vial
Sponsor: Bayer Australia Ltd
Company Detail Path: /organization/bayer-australia-ltd
Artg Date: 2004-07-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-03481-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2009-PI-01225-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

4f6d43d4de985bed

Type

Standard